merck glp-1 agonist GLP-1s Merck & Co. signs license

Description

State officials say health equity the idea that all groups regardless of background deserve equal access to health care is one of the main reasons they are considering the coverage, but that they worry higher costs will put pressure on their Medicaid budgets, said KFF senior policy analyst Liz Williams, who co-authored the survey of state Medicaid program directors

What are the risks associated with sarcopenia

Where can patients get reliable information about GLP-1 therapies

Dual agonists such as tirzepatide (GLP-1/GIP) have demonstrated superior weight loss and glycemic control compared to GLP-1 RAs alone, 104 likely due to complementary mechanisms involving both incretin pathways

Such interest could result in GLP-1 penetration reaching nearly 20% of the US adult population within two years, and the pill format could expand the active GLP-1 user population by as much as 50% by 2027, according to Big Chalk